It is generally recognized that APOE3 may confer resilience to tauopathies [97], while APOE4, especially the C-terminal truncated form (APOE4 Δ272–299), promotes tau phosphorylation/aggregation and exacerbates neurodegeneration [98–100]. This evidence concerns the gene MAPT and tauopathy.